Search Results - "LAU, Cecilia"
-
1
Curcumin: An age-old anti-inflammatory and anti-neoplastic agent
Published in Journal of Traditional and Complementary Medicine (01-07-2017)“…Curcumin is a natural anti-inflammatory agent that has been used for treating medical conditions for many years. Several experimental and pharmacologic trials…”
Get full text
Journal Article -
2
Preclinical evaluation of the mTOR–PI3K inhibitor BEZ235 in nasopharyngeal cancer models
Published in Cancer letters (01-02-2014)“…Abstract The dual PI3K–mTOR inhibitor BEZ235 was evaluated in preclinical models of nasopharyngeal carcinoma (NPC). The IC50 value of BEZ235 for growth was in…”
Get full text
Journal Article -
3
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines
Published in Investigational new drugs (01-06-2013)“…Summary Nasopharyngeal carcinoma (NPC) is endemic to Asia and over 40 % of NPC tissues harbor PIK3CA amplifications. This study characterized the preclinical…”
Get full text
Journal Article -
4
Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells
Published in Carcinogenesis (New York) (01-12-2009)“…Nasopharyngeal carcinoma (NPC) is an Asian-prevalent head and neck cancer with high invasiveness. Although several important risk factors for NPC development…”
Get full text
Journal Article -
5
Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma
Published in Investigational new drugs (01-12-2013)“…Summary Nasopharyngeal carcinoma (NPC) is common in Southeast Asia and over 40 % of NPC tissues have PIK3CA amplification. This study characterized the…”
Get full text
Journal Article -
6
Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalized with COVID-19: A protocol for a pragmatic clinical trial
Published in PloS one (23-03-2022)“…The use of broad-spectrum antibiotics is widespread in patients with COVID-19 despite a low prevalence of bacterial co-infection, raising concerns for the…”
Get full text
Journal Article -
7
The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines
Published in Investigational new drugs (01-08-2010)“…Summary Phosphorylated (pi-) protein kinase B (AKT) is commonly expressed in nasopharyngeal carcinoma (NPC) cell lines and tissues, suggesting the involvement…”
Get full text
Journal Article -
8
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma
Published in Cancer chemotherapy and pharmacology (01-06-2013)“…Purpose RAD001 targets at the mammalian target of rapamycin (mTOR), while TKI-258 is a potent tyrosine kinase inhibitor targeting at fibroblast growth factor…”
Get full text
Journal Article -
9
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma
Published in Investigational new drugs (01-12-2011)“…Summary Purpose : Sunitinib is a multi-target receptor tyrosine kinase (RTK) inhibitor against vascular endothelial growth factor receptors, platelet-derived…”
Get full text
Journal Article -
10
High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies
Published in Annals of surgical oncology (01-06-2007)“…Radiofrequency ablation (RFA) is a recently developed treatment for hepatocellular carcinoma (HCC). Thus far, the prognostic impact of tumor biomarkers has not…”
Get full text
Journal Article -
11
Tissue Factor Expression Correlates with Tumor Angiogenesis and Invasiveness in Human Hepatocellular Carcinoma
Published in Clinical cancer research (01-11-2003)“…Purpose: Recent studies have shown that tissue factor (TF) may be involved in tumor angiogenesis and metastasis. The role of TF in hepatocellular carcinoma…”
Get full text
Journal Article -
12
Significance of circulating endothelial progenitor cells in hepatocellular carcinoma
Published in Hepatology (Baltimore, Md.) (01-10-2006)“…This study evaluated the significance of circulating bone marrow‐derived endothelial progenitor cells (EPCs) in patients with hepatocellular carcinoma (HCC), a…”
Get full text
Journal Article -
13
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines
Published in Investigational new drugs (01-02-2013)“…Summary This study evaluated the preclinical activity of selumetinib (AZD6244, ARRY-142866), an inhibitor of the mitogen-activated protein kinase kinase (MAPKK…”
Get full text
Journal Article -
14
Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma
Published in Cancer research (Chicago, Ill.) (15-06-2003)“…Recent studies have suggested that serum levels of vascular endothelial growth factor (VEGF) may provide useful prognostic information in patients with various…”
Get full text
Journal Article -
15
Tumor Microvessel Density as a Predictor of Recurrence After Resection of Hepatocellular Carcinoma: A Prospective Study
Published in Journal of clinical oncology (01-04-2002)“…This study prospectively evaluated the correlation of tumor microvessel density (MVD) with clinicopathologic features and postoperative recurrence in patients…”
Get full text
Journal Article -
16
Predictors of Hazardous Drinking Behavior in 1,340 Adult Trauma Patients: A Computerized Alcohol Screening and Intervention Study
Published in Journal of the American College of Surgeons (01-10-2012)“…Background Alcohol screening and brief intervention (SBI) is used to decrease alcohol consumption, health care costs, and injury recidivism in trauma patients…”
Get full text
Journal Article -
17
Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584
Published in Cancer research (Chicago, Ill.) (01-05-2005)“…Vascular endothelial growth factor (VEGF) plays an important role in tumor angiogenesis of hepatocellular carcinoma. Inhibition of VEGF receptors could…”
Get full text
Journal Article -
18
Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma
Published in World journal of gastroenterology : WJG (07-04-2005)“…AIM: Recent studies suggested that cyclooxygenase-2 (COX-2) enhances tumor angiogenesis via upregulation of vascular endothelial growth factor (VEGF). Although…”
Get full text
Journal Article -
19
Clinical Significance of Thrombospondin 1 Expression in Hepatocellular Carcinoma
Published in Clinical cancer research (15-06-2004)“…Purpose: Thrombospondin 1 (THBS 1) is a matricellular protein capable of modulating angiogenesis. However, the actual role of THBS 1 in angiogenesis and tumor…”
Get full text
Journal Article -
20
TP53-induced glycolysis and apoptosis regulator promotes proliferation and invasiveness of nasopharyngeal carcinoma cells
Published in Oncology letters (01-02-2015)“…The TP53-induced glycolysis and apoptosis regulator (TIGAR) is the protein product of the p53 target gene, C12orf5. TIGAR blocks glycolysis and promotes…”
Get full text
Journal Article